A Study to Evaluate IBI112 in the Treatment of Psoriasis With Moderate to Severe Plaque Psoriasis
Status:
Recruiting
Trial end date:
2023-01-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of IBI112 administered in
different dose regimens for the treatment of patients with plaque psoriasis